Viewing StudyNCT06533384



Ignite Creation Date: 2024-10-25 @ 8:01 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06533384
Status: RECRUITING
Last Update Posted: None
First Post: 2024-04-06

Brief Title: PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
Sponsor: None
Organization: None

Conditions & Keywords Data

Conditions:
Keywords: